Globe Life (GL) stock: key figures, P/E, revenue and dividend

Financials · Life & Health Insurance · United States · ISIN US37959E1029

Price
167.41 USD
Market cap
12.87 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.75 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Globe Life financials

Fiscal year2025
Revenue5.99 bn USD
EBIT1.58 bn USD
Net income1.16 bn USD
Diluted EPS – continuing operations14.07 USD

Full history since 1985, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Globe Life

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Globe Life stock (GL): P/E, revenue, dividend | finmetric